The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE still firmer ahead of US inflation print

Tue, 12th Dec 2023 12:07

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Investors were also awaiting a crucial US inflation reading and several central bank policy announcements scheduled for later in the week.

At midday, the FTSE 100 was up 0.4% at 7,575.37 points, while the FTSE 250 was down 0.09% at 18,734.32.

In currency markets, sterling was last up 0.09% on the dollar at $1.2566, while it faced a slight setback against the euro, declining 0.2% to €1.1641.

"European markets are enjoying a largely positive start to the day today, with the FTSE 100 gaining ground off the back of an eventful jobs report," said Scope Markets chief market analyst Joshua Mahony.

"Of particular note was the greater-than-expected slump in UK average earnings, with the total pay figure dropping from 8% to 7.2%.

"While this 0.8% decline helped raise hope that this period of wage normalisation might be hastened, the fact remains that UK earnings growth remains far too high as highlighted by the fact that only Argentina has a higher wage growth figure of all G20 nations."

Mahony said the substantial gap between earnings and inflation was helping to repair some of the damage done to UK households over the last year, with sky-high inflation having driven real wages lower to the detriment of spending and savings.

"While the claimant count pushed up into a five-month high, we remain within 'soft-landing' territory that should allow the Bank of England to continue squeezing most of the above-target inflation out of the economy before pivoting towards a more dovish policy stance."

Unemployment rate remains unchanged in October

In economic news, official data released earlier indicated that the number of unemployed people in the UK in October remained unchanged, coinciding with a cooling trend in wage growth.

According to the Office for National Statistics' latest provisional data, the unemployment rate held steady at 4.2% during the three months leading up to October.

Likewise, the economic inactivity rate remained essentially unchanged at 20.9%.

Annual growth in total pay registered at 7.2%, or 7.3% when excluding bonuses, marking a decline compared to the prior month's growth of 7.7% and falling short of analysts' expectations for 7.5% growth in regular pay.

Adjusted for inflation, annual total pay saw a 1.3% increase, while regular pay grew by 1.4%.

Furthermore, the number of job vacancies saw a decline of 45,000 in September, dropping to 949,000 for the period spanning from September to November.

That marked the 17th consecutive quarterly decrease in vacancies, constituting the longest unbroken run of such declines ever recorded.

In November, 30.2 million individuals were payrolled employees, reflecting a decrease of 13,000 compared to the revised figure for October.

"The pay data is clearly now moving in the right direction from the perspective of the Monetary Policy Committee," said Martin Beck, chief economic advisor to the EY Item Club.

"But given that annual pay growth is still running at more than twice the pace that would be consistent with the Bank of England's 2% inflation target, the MPC is likely to stick with its 'high-for-longer' message for a little while yet."

In Germany, a widely-watched survey revealed an uptick in investor sentiment despite the country's economic challenges.

The latest ZEW indicator of economic sentiment posted a reading of 12.8, a three-point increase from November's figure and surpassing consensus expectations for a reading of 8.8.

While the assessment of the current economic situation also improved by 2.7 points, it remained firmly in negative territory at -77.1.

AstraZeneca up on acquisition news, BT and Vodafone fall

On London's equity markets, AstraZeneca saw gains as it announced its agreement to acquire US vaccine maker Icosavax for up to $1.1bn.

The mining sector demonstrated resilience after facing substantial losses in the previous session.

Rio Tinto, Antofagasta, and Glencore all rebounded significantly, with their stock prices experiencing notable increases.

On the downside, Hargreaves Lansdown and AJ Bell were in the red after the Financial Conduct Authority (FCA) disclosed its concerns regarding how investment platforms and self-invested personal pension (SIPP) operators managed interest earned on customers' cash balances.

BT Group and Vodafone Group also found themselves on a downward trajectory following Ofcom's proposal to prohibit inflation-linked mid-contract price increases.

Reporting by Josh White for Sharecast.com.

FTSE 100 - Risers

Rio Tinto (RIO) 5,607.00p 2.24%

Ocado Group (OCDO) 646.40p 2.21%

Pershing Square Holdings Ltd NPV (PSH) 3,330.00p 2.15%

Rightmove (RMV) 593.20p 1.99%

Antofagasta (ANTO) 1,563.00p 1.76%

AstraZeneca (AZN) 10,270.00p 1.72%

Compass Group (CPG) 2,096.00p 1.50%

InterContinental Hotels Group (IHG) 7,006.00p 1.36%

Smith & Nephew (SN.) 1,061.00p 1.14%

Legal & General Group (LGEN) 243.00p 1.12%

FTSE 100 - Fallers

Hargreaves Lansdown (HL.) 709.20p -7.32%

BT Group (BT.A) 126.35p -3.81%

Admiral Group (ADM) 2,725.00p -2.61%

St James's Place (STJ) 679.00p -1.96%

Vodafone Group (VOD) 67.22p -1.94%

Anglo American (AAL) 1,761.20p -1.55%

Prudential (PRU) 883.40p -1.47%

Airtel Africa (AAF) 114.30p -1.30%

Schroders (SDR) 418.60p -1.06%

NATWEST GROUP (NWG) 217.20p -0.78%

FTSE 250 - Risers

International Distributions Services (IDS) 265.80p 9.74%

TUI AG Reg Shs (DI) (TUI) 624.00p 2.97%

Virgin Money UK (VMUK) 157.20p 2.68%

SDCL Energy Efficiency Income Trust (SEIT) 60.70p 2.53%

Spectris (SXS) 3,600.00p 2.45%

Energean (ENOG) 1,012.00p 1.86%

NCC Group (NCC) 123.20p 1.82%

Spirent Communications (SPT) 113.50p 1.79%

Darktrace (DARK) 367.50p 1.69%

Games Workshop Group (GAW) 9,260.00p 1.48%

FTSE 250 - Fallers

AJ Bell (AJB) 287.40p -7.77%

Abrdn (ABDN) 173.25p -4.28%

Wizz Air Holdings (WIZZ) 1,967.00p -4.24%

Digital 9 Infrastructure NPV (DGI9) 30.90p -4.04%

Helios Towers (HTWS) 69.05p -3.83%

Quilter (QLT) 97.00p -2.81%

Pennon Group (PNN) 730.50p -2.66%

Watches of Switzerland Group (WOSG) 698.00p -2.38%

IP Group (IPO) 48.10p -2.24%

Target Healthcare Reit Ltd (THRL) 81.00p -2.17%

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.